Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    IDEXX Laboratories Inc.

    NASDAQ: IDXX · Real-Time Price · USD
    530.48
    5.83 (1.11%)
    At close: Jun 24, 2025, 3:59 PM
    531.81
    0.25%
    After-hours: Jun 24, 2025, 06:02 PM EDT
    1.11%
    Bid 503
    Market Cap 42.66B
    Revenue (ttm) 3.93B
    Net Income (ttm) 894.97M
    EPS (ttm) 10.81
    PE Ratio (ttm) 49.07
    Forward PE 38.38
    Analyst Buy
    Ask 563.27
    Volume 205,400
    Avg. Volume (20D) 792,593
    Open 524.65
    Previous Close 524.65
    Day's Range 520.36 - 530.74
    52-Week Range 356.14 - 530.74
    Beta 1.55

    About IDXX

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol IDXX
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for IDXX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    IDEXX Laboratories Inc. is scheduled to release its earnings on Aug 5, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    +8.95%
    IDEXX Laboratories shares are trading higher after... Unlock content with Pro Subscription
    4 months ago
    +11.13%
    IDEXX Laboratories shares are trading higher after the company reported better-than-expected Q4 earnings and revenue.
    news image

    1 day ago · businesswire.com

    IDEXX Laboratories to Release 2025 Second Quarter Financial Results

    WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 second quarter financial results for Mon...

    news image

    1 month ago · zacks.com

    5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil

    Five high-flying medical instrument stocks are: DXCM, IDXX, NPCE, CLPT, FMS.

    news image

    1 month ago · seekingalpha.com

    IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

    IDEXX Laboratories, Inc. delivered strong Q1 FY25 results with 4.7% organic revenue and 7% adjusted EPS growth, despite weak US clinical visits. I see catalysts ahead: potential U.S. tax cuts, normali...

    news image

    1 month ago · zacks.com

    Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

    Here is how Idexx Laboratories (IDXX) and AngioDynamics (ANGO) have performed compared to their sector so far this year.

    news image

    1 month ago · businesswire.com

    IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

    WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Andrew Emerson, Executive Vice President and Chief Financ...

    news image

    1 month ago · zacks.com

    Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

    Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street es...

    news image

    1 month ago · seekingalpha.com

    IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript

    IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Andrew Emerson - EVP, CFO and Treasurer Jay Mazelsky - President and CEO Conference...

    news image

    1 month ago · zacks.com

    Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates

    Idexx Laboratories (IDXX) came out with quarterly earnings of $2.96 per share, beating the Zacks Consensus Estimate of $2.92 per share. This compares to earnings of $2.81 per share a year ago.

    news image

    1 month ago · reuters.com

    IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics

    Animal diagnostics maker IDEXX Laboratories on Thursday raised its annual profit forecast after it beat Wall Street estimates for quarterly profit, as it benefited from customer retention and increase...

    news image

    1 month ago · businesswire.com

    IDEXX Laboratories Announces First Quarter Results

    WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. “IDEXX drove solid execution in the fir...

    Add to Watchlist